BOIRF (Boiron) OCF Yield %: 11.07 (As of Jun. 27, 2026) — 34% Above Median


BOIRF Boiron SA BOIRF
62 GF Score
Price $31.90
GF Value $33.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Boiron OCF Yield %?

Boiron BOIRF 62 OCF Yield % is 11.07 as of Jun. 27, 2026, which is 34% above its 10-year median of 8.29. GuruFocus rates BOIRF with a GF Score™ of 62/100 and a GF Value™ of $33.65 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Boiron ranks better than 81% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Boiron's Trailing 12-Month Cash Flow from Operations is $61.9 Mil, and Market Cap is $556.3 Mil. Therefore, Boiron's OCF Yield % for today is 11.07%.

The historical rank and industry rank for Boiron's OCF Yield % or its related term are showing as below:

BOIRF' s OCF Yield % Range Over the Past 10 Years
Min: 3.75   Med: 8.29   Max: 15.03
Current: 11.07


During the past 13 years, the highest OCF Yield % of Boiron was 15.03%. The lowest was 3.75%. And the median was 8.29%.

BOIRF's OCF Yield % is ranked better than
81% of 1005 companies
in the Drug Manufacturers industry
Industry Median: 3.61 vs BOIRF: 11.07

Boiron's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Boiron OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Boiron OCF Yield % Related Terms


Boiron OCF Yield % Historical Data

* Premium members only.

The historical data trend for Boiron's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boiron OCF Yield % Chart

Boiron Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.83 8.25 5.34 8.37 11.97

Boiron Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.83 4.99 11.00 12.55 11.83

BOIRF vs ZTS, UTHR, VTRS: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boiron OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Boiron's OCF Yield % falls into.


BOIRF
62GF Score
Boiron SA BOIRF
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boiron OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Boiron's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=62.342 / 520.86
=11.97%

Boiron's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=30.814 * 2 / 520.86
=11.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 11.07 mean?
Boiron (BOIRF) has a OCF Yield % of 11.07 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Boiron and its competitors. This is 34% above median its historical median of 8.29. Over the past decade, Boiron's OCF Yield % has ranged from 3.75 to 15.03. According to the industry distribution chart, Boiron ranks #191 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 19%.
Is Boiron's OCF Yield % too high?
Boiron's current OCF Yield % of 11.07 is 34% above median its 10-year median of 8.29. Over the past 10 years, this metric has ranged from a low of 3.75 to a high of 15.03. The Drug Manufacturers industry median OCF Yield % is 3.61. Boiron's value of 11.07 is 206.6% above this industry median. Based on the distribution chart, Boiron ranks #191 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Boiron has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Boiron's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Boiron ranks #191 out of 1005 companies for OCF Yield %. This places Boiron in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.61. Boiron's value of 11.07 is 206.6% above this benchmark. Historically, Boiron's own OCF Yield % has ranged from 3.75 to 15.03 over the past decade. While the company's 10-year median is 8.29 vs. the industry median of 3.61, Boiron has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Boiron's current OCF Yield % of 11.07 is 206.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Boiron and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boiron's current OCF Yield % is 11.07, which is 34% above median its own 10-year median of 8.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boiron stock overvalued right now?
Based on GuruFocus' analysis, Boiron (BOIRF) is currently considered Fairly Valued. The stock's GF Value™ is $33.65, compared to a current price of $31.90 — trading 5.2% below its estimated fair value. The current OCF Yield % is 11.07, which is 34% above median its 10-year median of 8.29 and 206.6% above the Drug Manufacturers industry median of 3.61. Boiron's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Boiron (BOIRF), the current OCF Yield % is 11.07 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boiron (BOIRF) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of $31.90 is trading 5.2% below its estimated GF Value™ of $33.65. GuruFocus considers Boiron to be Fairly Valued.

Key valuation signals for BOIRF:

  • OCF Yield %: 11.07 (34% above median its 10-year median of 8.29)
  • GF Value™: $33.65 vs. price of $31.90 (5.2% below fair value)
  • GF Score™: 62/100 with 5 warning signs
  • Industry Position: 206.6% above the Drug Manufacturers median (#191 of 1005)

No single metric tells the full story. See the BOIRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boiron Business Description

Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
62GF Score

Get the complete analysis for BOIRF

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.90
Price
$33.65
GF Value